TRPX - Therapix Biosciences Ltd.

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2018-12-30
2017-12-30
2016-12-30
2015-12-30
Total Revenue
0
0
0
-
-
Cost of Revenue
-
-
-
-
-
Gross Profit
-
-
-
-
-
Operating Expenses
Research Development
3,308
4,058
2,017
739
238
Selling General and Administrative
3,933
4,463
3,736
1,290
804
Total Operating Expenses
9,007
9,289
5,753
2,031
2,596
Operating Income or Loss
-9,007
-9,289
-5,753
-2,031
-2,596
Interest Expense
-
123
5
1
0
Total Other Income/Expenses Net
-
-122
-487
34
-6
Income Before Tax
-9,097
-9,009
-6,244
-2,004
-2,606
Income Tax Expense
-
-60
-
-
-
Income from Continuing Operations
-9,037
-8,949
-6,244
-2,004
-2,606
Net Income
-8,611
-8,523
-6,244
-1,990
-2,530
Net Income available to common shareholders
-8,611
-8,523
-6,244
-1,990
-2,530
Reported EPS
Basic
-
-2.40
-2.00
-2.18
-4.41
Diluted
-
-2.40
-2.00
-2.18
-4.41
Weighted average shares outstanding
Basic
-
3,498
2,919
936
596
Diluted
-
3,984
2,919
936
596
EBITDA
-
-8,739
-6,234
-1,999
-2,603